TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14623488

Group type: EXPERIMENTAL
Intervention: 100ml of bottled drinking water with 0.4mg of copper (Cu)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: 150ml of bottled drinking water with 0.8mg of copper (Cu)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: 200ml of bottled drinking water with 1.2mg of copper (Cu)
Number of subjects: 269

Group type: COMPARATOR
Intervention: 200ml of bottled drinking water with 0mg of copper (Cu)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: 200ml of bottled drinking water with 1.6mg of copper (Cu)
Number of subjects: 269
Study: 10493218

Group type: EXPERIMENTAL
Intervention: Ketorolac
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dalteparin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ketorolac and Dalteparin
Number of subjects: 0
Study: 8710963

Group type: EXPERIMENTAL
Intervention: Stretching group
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study: 1677695

Group type: EXPERIMENTAL
Intervention: Lumpectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lumpectomy plus breast irradiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total mastectomy
Number of subjects: 0
Study: 6354933

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg three times daily (t.i.d.)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg twice daily (b.i.d.)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Captopril 50 mg three times daily (t.i.d.)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Captopril 50 mg twice daily (b.i.d.)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg three times daily (t.i.d.) with chlorthalidone 25 mg daily
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg twice daily (b.i.d.) with chlorthalidone 25 mg daily
Number of subjects: 30
Study: 31875936

Group type: EXPERIMENTAL
Intervention: Baseline UA levels < 5.0 mg/dL
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Baseline UA levels 5.0-6.0 mg/dL
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Baseline UA levels 6.0-7.0 mg/dL
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Baseline UA levels ≥ 7.0 mg/dL
Number of subjects: 279
Study: 30779295

Group type: EXPERIMENTAL
Intervention: Sildenafil (25 mg orally three times daily until 32+0 weeks, birth, or fetal death)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (visually matching placebo three times daily until 32+0 weeks, birth, or fetal death)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 29025605

Group type: EXPERIMENTAL
Intervention: CarboFix volar locking plate (Group A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Acu-Lock Volar Distal Radius Plate (Group B)
Number of subjects: 30
Study: 26280699

Group type: EXPERIMENTAL
Intervention: Ozonated oil and α-bisabolol formulation
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control cream (vitamin A, vitamin E, talc, and zinc oxide)
Number of subjects: 29
Study: 23740278

Group type: EXPERIMENTAL
Intervention: High-volume haemofiltration (HVHF) at 70 mL/kg/h
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard-volume haemofiltration (SVHF) at 35 mL/kg/h
Number of subjects: 140
Study: 21376385

Group type: EXPERIMENTAL
Intervention: Eribulin mesilate (1·4 mg/m² administered intravenously during 2‐5 min on days 1 and 8 of a 21‐day cycle)
Number of subjects: 762

Group type: COMPARATOR
Intervention: Treatment of physician's choice (TPC)
Number of subjects: 762

Group type: EXPERIMENTAL
Intervention: Eribulin
Number of subjects: 762

Group type: COMPARATOR
Intervention: TPC
Number of subjects: 762
Study: 18193194

Group type: EXPERIMENTAL
Intervention: Single-bundle (SB) technique with a 4-stranded semitendinosus (ST) graft
Number of subjects: 50

Group type: COMPARATOR
Intervention: Double-bundle (DB) technique with a 2-stranded ST graft
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both techniques (SB and DB)
Number of subjects: 50
Study: 16491283

Group type: EXPERIMENTAL
Intervention: hPTH(1-34) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (quadruple-labeled without hPTH(1-34))
Number of subjects: 0
Study: 14678901

Group type: EXPERIMENTAL
Intervention: Normothermic cardiopulmonary bypass (CPB, study group, n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hypothermic cardiopulmonary bypass (control group, n=20)
Number of subjects: 40
Study: 11314498

Group type: EXPERIMENTAL
Intervention: Helmet treatment
Number of subjects: 105

Group type: COMPARATOR
Intervention: Nonhelmet treatment
Number of subjects: 105
Study: 8857040

Group type: EXPERIMENTAL
Intervention: Oral bile salts (500 mg of sodium deoxycholate 8-hourly for 48 hours preoperatively)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Bile refeeding (total bile output for the entire period of biliary drainage, median 13 days)
Number of subjects: 16
Study: 10148188

Group type: EXPERIMENTAL
Intervention: Calf blood dialysate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 6527988

Group type: EXPERIMENTAL
Intervention: 3 to 5 min of behavioral cessation counseling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Minimal warning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral counseling among normal PFT subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral counseling among abnormal PFT subjects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Minimal warning among normal PFT subjects
Number of subjects: 0
Study: 30716613

Group type: EXPERIMENTAL
Intervention: TAU + AAMT
Number of subjects: 105

Group type: COMPARATOR
Intervention: TAU + Sham
Number of subjects: 105
Study: 30187504

Group type: EXPERIMENTAL
Intervention: Face-to-face interview
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Self-administered questionnaire
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Telephone interview
Number of subjects: 42
Study: 27768792

Group type: EXPERIMENTAL
Intervention: DEX implant (4 monthly)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Bevacizumab (monthly, pro re nata)
Number of subjects: 48
Study: 24352752

Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 28

Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 28
Study: 23036921

Group type: EXPERIMENTAL
Intervention: Amoxicillin 3g per os
Number of subjects: 286

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 286
Study: 20676837

Group type: EXPERIMENTAL
Intervention: Bleeding complications
Number of subjects: 331

Group type: COMPARATOR
Intervention: No bleeding complications
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Elevated troponin level
Number of subjects: 331
Study: 17309342

Group type: EXPERIMENTAL
Intervention: Abacavir sulfate/lamivudine/zidovudine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Protease inhibitor-based regimens (e.g., indinavir)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Efavirenz-based regimens
Number of subjects: 0
Study: 16392280

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (without beta‐blockers)
Number of subjects: 150
Study: 12356784

Group type: EXPERIMENTAL
Intervention: Oral arginine (3 grams per hour for 10 hours)
Number of subjects: 6
Study: 10447630

Group type: EXPERIMENTAL
Intervention: Type VI collagen expression in arthrofibrotic tissue
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Histologic analysis of arthrofibrotic tissue
Number of subjects: 13

Group type: COMPARATOR
Intervention: Comparison with normal synovial tissue
Number of subjects: 13
Study: 7787408

Group type: EXPERIMENTAL
Intervention: Amino acid-enriched glucose-insulin-potassium infusion (group A)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 44
Study: 2338694

Group type: EXPERIMENTAL
Intervention: Exercise training (42 minutes, three times a week for 12 weeks, intensity 60‐70% of heart rate reserve)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 10
Study: 375436

Group type: EXPERIMENTAL
Intervention: Butriptyline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional antacid therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Larger ulcers
Number of subjects: 0
Study: 31793171

Group type: EXPERIMENTAL
Intervention: AZD5718 (200 mg) coadministered with Rosuvastatin (10 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: AZD5718 (200 mg) as tablets
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: AZD5718 (200 mg) tablets after high-fat breakfast
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: AZD5718 (200 mg) once-daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: AZD5718
Number of subjects: 12
Study: 30653422

Group type: EXPERIMENTAL
Intervention: AHCT/AHCT + len
Number of subjects: 758

Group type: EXPERIMENTAL
Intervention: AHCT + RVD + len
Number of subjects: 758

Group type: EXPERIMENTAL
Intervention: AHCT + len
Number of subjects: 758
Study: 28537583

Group type: EXPERIMENTAL
Intervention: Reduced n-6:n-3 LCPUFA ratio diet (1.2g n-3 LCPUFA with AA-balanced diet from 15th week of gestation to 4 months postpartum)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Reduced n-6:n-3 LCPUFA ratio diet
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Higher cord blood concentrations of docosahexaenoic acid, eicosapentaenoic acid, and AA
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 119
Study: 25179768

Group type: EXPERIMENTAL
Intervention: TRO40303
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study: 23324408

Group type: EXPERIMENTAL
Intervention: Erythromycin 250 mg orally QID
Number of subjects: 30

Group type: COMPARATOR
Intervention: Neomycin 1 g orally QID
Number of subjects: 30
Study: 20663992

Group type: EXPERIMENTAL
Intervention: AMG 221 (3, 30, or 100 mg)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 19846683

Group type: EXPERIMENTAL
Intervention: Multisensory stimulation environments (MSSE)
Number of subjects: 0
Study: 17075375

Group type: EXPERIMENTAL
Intervention: Intrapulmonary percussive ventilation (IPV)
Number of subjects: 40
Study: 15584488

Group type: EXPERIMENTAL
Intervention: Naproxen (Aleve)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ibuprofen (Advil)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acetaminophen (Tylenol)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All medications
Number of subjects: 60

Group type: COMPARATOR
Intervention: Acetaminophen
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Naproxen and Ibuprofen
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All three medications
Number of subjects: 60
Study: 11710407

Group type: EXPERIMENTAL
Intervention: 1200 ml of distilled water (trial 2)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 1200 ml of Gatorade (trial 3)
Number of subjects: 11

Group type: COMPARATOR
Intervention: No fluid (trial 1)
Number of subjects: 11
Study: 9280886

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 60
Study: 8000803

Group type: EXPERIMENTAL
Intervention: 8% red cell suspension with diluted commercial sera hyperimmune to Salmonellae and Yersinia, serovars O3 and O9
Number of subjects: 0
Study: 3571772

Group type: EXPERIMENTAL
Intervention: L-649,923 (1000 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 29629731

Group type: EXPERIMENTAL
Intervention: Eplerenone (n=8)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Spironolactone (n=16)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Eplerenone and Spironolactone
Number of subjects: 24
Study: 27739263

Group type: EXPERIMENTAL
Intervention: Carica papaya leaf extract capsule (500 mg once daily for 5 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine supportive treatment
Number of subjects: 0
Study: 23975179

Group type: EXPERIMENTAL
Intervention: Standard-dose cytarabine and anthracycline with risk-adapted remission induction regimen (7+3)
Number of subjects: 795
Study: 22568647

Group type: EXPERIMENTAL
Intervention: ALEXIS wound retractor
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional wound protection
Number of subjects: 34
Study: 20731651

Group type: EXPERIMENTAL
Intervention: Intense Pulsed Light (IPL)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Long-Pulsed Diode Laser (LPDL)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Intense Pulsed Light (IPL) and Long-Pulsed Diode Laser (LPDL)
Number of subjects: 31
Study: 19035420

Group type: EXPERIMENTAL
Intervention: Wrist working splint
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no splint)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Nonsplinted grip strength
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Functional ability (measured using the Disabilities of the Arm, Shoulder, and Hand questionnaire and the short version of the Sequential Occupational Dexterity Assessment)
Number of subjects: 33
Study: 15604591

Group type: COMPARATOR
Intervention: Cisplatin monotherapy (37.5 mg/m² on days 1 + 2 of 4-week schedules)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cisplatin/Ifosfamide/5-Fluorouracil (PIF) regimen (Cisplatin same as above, Ifosfamide 2 g/m², Mesna 0.5 g/m², 5-Fluorouracil 500 mg/m², Folinic acid 30 mg/m² on days 1 + 2, all on 4-week schedules)
Number of subjects: 21
Study: 12441265

Group type: COMPARATOR
Intervention: CMF (cyclophosphamide, methotrexate, 5‐fluorouracil)
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Epirubicin
Number of subjects: 348
Study: 10627742

Group type: EXPERIMENTAL
Intervention: Fully cemented stem
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Proximally cemented stem
Number of subjects: 12
Study: 9389673

Group type: EXPERIMENTAL
Intervention: Urgent ERCP within 72 hours after the beginning of pain
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional treatment (ERCP only if biliary sepsis or obstructive jaundice occurred)
Number of subjects: 100
Study: 1914053

Group type: EXPERIMENTAL
Intervention: diazepam 10 mg (n = 31)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: propranolol 80 mg (n = 31)
Number of subjects: 92

Group type: COMPARATOR
Intervention: placebo (n = 30)
Number of subjects: 92
Study: 6456870

Group type: EXPERIMENTAL
Intervention: Buf-Puf epidermabrasion in combination with benzoyl peroxide (BPO)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Benzoyl peroxide (BPO) alone
Number of subjects: 48
Study: 6742394

Group type: EXPERIMENTAL
Intervention: Midazolam (0.17 mg/kg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Diazepam (0.32 mg/kg)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Midazolam and Diazepam
Number of subjects: 34
Study: 30014565

Group type: EXPERIMENTAL
Intervention: Active oral appliance (OA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham oral appliance (OA)
Number of subjects: 0
Study: 27932937

Group type: EXPERIMENTAL
Intervention: Electrolyzed, high-pH (alkaline) water
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard purified water
Number of subjects: 100
Study: 25560330

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (3 times a week for 8 weeks, including warm-up, walking at 60% max heart rate, and stretching)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (no aerobic exercise)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 53
Study: 22706631

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (median daily doses of 1,400 IU)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Willingness to participate in a vitamin D supplementation RCT
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Feasibility criteria for RCT participation
Number of subjects: 173
Study: 20547658

Group type: EXPERIMENTAL
Intervention: Certolizumab pegol (CZP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Certolizumab pegol (CZP) responders
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 18580847

Group type: EXPERIMENTAL
Intervention: L-5-hydroxytryptophan (5-HTP)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 16041207

Group type: EXPERIMENTAL
Intervention: 5-FU + LEV + FA
Number of subjects: 855

Group type: COMPARATOR
Intervention: 5-FU + LEV
Number of subjects: 855

Group type: EXPERIMENTAL
Intervention: 5-FU + LEV + INF-alpha
Number of subjects: 855
Study: 11856687

Group type: EXPERIMENTAL
Intervention: Color Doppler sonography
Number of subjects: 55

Group type: COMPARATOR
Intervention: Helical CT
Number of subjects: 55
Study: 10421299

Group type: EXPERIMENTAL
Intervention: Laparoscopic repair
Number of subjects: 928
Study: 9002912

Group type: EXPERIMENTAL
Intervention: Bionator
Number of subjects: 191

Group type: COMPARATOR
Intervention: Headgear/Bite Plane
Number of subjects: 191

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 191
Study: 1978873

Group type: EXPERIMENTAL
Intervention: Amoxycillin 500 mg plus probenecid 500 mg three times a day for 21 days
Number of subjects: 72

Group type: COMPARATOR
Intervention: Doxycycline 100 mg twice a day for 21 days
Number of subjects: 72
Study: 6989482

Group type: EXPERIMENTAL
Intervention: Presymptomatic gonadal radiation immediately after achieving initial marrow remission
Number of subjects: 395

Group type: COMPARATOR
Intervention: Discontinued therapy after completing three years of continuous complete remission
Number of subjects: 395

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 395
Study: 31345186

Group type: EXPERIMENTAL
Intervention: Health promotion session delivered to groups of students (not more than 25 at a time) by trained facilitators.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (students from the control school).
Number of subjects: 0
Study: 29485305

Group type: EXPERIMENTAL
Intervention: e-CHECKUP TO GO program (e-CHUG)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Assessment-only control condition
Number of subjects: 245
Study: 26916717

Group type: EXPERIMENTAL
Intervention: Preoperative Chemotherapy (ChT)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Preoperative Chemoradiation (ChRT)
Number of subjects: 214
Study: 24787992

Group type: EXPERIMENTAL
Intervention: 33-gauge microneedle
Number of subjects: 20

Group type: COMPARATOR
Intervention: 30-gauge microneedle
Number of subjects: 20
Study: 22252796

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate 220 mg (test treatment)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Enoxaparin 40 mg administered subcutaneously once daily for 3 days
Number of subjects: 23

Group type: COMPARATOR
Intervention: Enoxaparin pre-treatment
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate and Enoxaparin
Number of subjects: 23
Study: 19282708

Group type: EXPERIMENTAL
Intervention: 5% EMLA cream
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1% lidocaine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 90
Study: 17621023

Group type: EXPERIMENTAL
Intervention: Vasoactive prophylaxis consisting of nimodipine and hydroxyethylstarch, started the day before surgery and continued until the seventh postoperative day.
Number of subjects: 30

Group type: COMPARATOR
Intervention: No preoperative medication (control group).
Number of subjects: 30
Study: 15846258

Group type: EXPERIMENTAL
Intervention: Enoxaparin throughout index hospitalization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment with unfractionated heparin (UFH) as adjunctive antithrombin therapy
Number of subjects: 0
Study: 11598429

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioural Therapy (CBT)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: CBT + Fluoxetine (FLX)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: CBT + Fluvoxamine (FLV)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Fluoxetine (FLX)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Fluvoxamine (FLV)
Number of subjects: 108
Study: 9161352

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (150 mg daily for 28 days)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 7966841

Group type: EXPERIMENTAL
Intervention: Smoking intervention plus bronchodilator
Number of subjects: 5887

Group type: EXPERIMENTAL
Intervention: Smoking intervention plus placebo
Number of subjects: 5887

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 5887

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (bronchodilator)
Number of subjects: 5887
Study: 3308058

Group type: EXPERIMENTAL
Intervention: Flexible sigmoidoscopy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rigid sigmoidoscopy
Number of subjects: 0
Study: 30772854

Group type: EXPERIMENTAL
Intervention: BIP TIC ERP
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: BIP TIC HRT
Number of subjects: 23
Study: 28285617

Group type: EXPERIMENTAL
Intervention: Bee propolis (300 mg three times a day for a total of 900 mg/d)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo (similar pills lacking propolis)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: No significant difference reported for other lipids or insulin resistance indices between the two groups.
Number of subjects: 66
Study: 25902613

Group type: EXPERIMENTAL
Intervention: WinFood (locally produced complementary foods based on traditional animal-source foods)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corn-soy blend (CSB)
Number of subjects: 0
Study: 24051384

Group type: EXPERIMENTAL
Intervention: Auto‐Trak system during PSV
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventional settings (pressure support of 8 cm H2O with flow cycling)
Number of subjects: 12
Study: 20571404

Group type: EXPERIMENTAL
Intervention: Training Group (TG) - moderate-intensity aerobic exercise using a bike or treadmill for 45 min, 3-5 times a week, combined with high-intensity inspiratory muscle training for 10 weeks
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Training Group (TG)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 15